Integrated Experimental and Computational Evaluation of Tri(p‐tolyl)phosphonium–Hydrazide Salts as AChE Inhibitors With Antimicrobial and Antibiofilm Activity Against Resistant Acinetobacter baumannii
5 affiliations
- 1Department of Biochemistry, Faculty of Pharmacy Cukurova University Adana Türkiye
- 2Department of Chemistry, Faculty of Science Eskisehir Technical University Eskisehir Türkiye
- 3Department of Pharmacy Services, Vocational School of Health Services Harran University Sanliurfa Türkiye
- 4Faculty of Pharmacy Harran University Sanliurfa Türkiye
- 5Department of Chemistry Faculty of Art and Science Cukurova University Adana Türkiye
Abstract
The rapid increase in multidrug‐resistant bacterial infections, particularly those caused by carbapenem‐resistant pathogens, represents an escalating global threat and necessitates the development of novel antimicrobial agents. In this study, a new series of tri(p‐tolyl)phosphonium‐hydrazide salts (1a–1g) was synthesized and structurally characterized using 1H‐NMR, 13C‐NMR, 31P‐NMR, and HR‐MS techniques. The antibacterial activity of the derivatives was assessed against carbapenem‐resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae, along with antibiofilm efficacy against A. baumannii. Compound 1d demonstrated the strongest antibacterial performance with a minimum inhibitory concentration value of 8 µg/mL against carbapenem‐resistant A. baumannii, and exhibited potent inhibition against the remaining strains. Given the multitarget therapeutic value, AChE inhibition was additionally evaluated, where compounds 1d and 1e showed appreciable activity with IC50 values of 5.392 µg/mL and 5.390 µg/mL, respectively. Molecular docking studies were conducted against clinically relevant protein targets (PDB: 4EY7, 6MPQ, 6GIE, 6OWS, 4DUH, 4DX5, and 4WUB) to further support the experimental outcomes. Compound 1d exhibited the highest binding affinity toward 6OWS with a docking score of −6.743 kcal/mol, correlating with its pronounced antibacterial efficacy. Collectively, these findings suggest that compound 1d holds promise as a potent antimicrobial candidate against drug‐resistant bacterial infections while also offering secondary therapeutic potential through AChE inhibition.
Related
- Robust marine bacterium-mediated synthesis of Cu-ZnO nanocomposites: a novel antibiofilm and antivirulent strategy to combat carbapenem-resistant Acinetobacter baumannii
- Novel Pd(II) Rollover Complexes with Antimicrobial and Antibiofilm Activity
- Heteroaryl-Substituted Secondary Amines as Multifunctional Antimicrobial, Antibiofilm, Acetylcholinesterase, and α-Glucosidase Inhibitors
- Design, synthesis, and biological evaluation of imidazole-triazole hybrids as dual antimicrobial and antioxidant agents: experimental and in silico studies
- Integrated Experimental and Computational Investigation of Fluorinated Benzoylthiourea Derivatives: Structural Characterization, Hirshfeld Surface Analysis, Antioxidant Activity, and MAO–B Inhibitory Potential for Parkinson’s Disease
BibTeX
@article{yıldırım2026integrated,
title = {{Integrated Experimental and Computational Evaluation of Tri(p‐tolyl)phosphonium–Hydrazide Salts as AChE Inhibitors With Antimicrobial and Antibiofilm Activity Against Resistant Acinetobacter baumannii}},
author = {Metin Yıldırım and Hakan Ünver and Adem Necip and Büsra Hord and Mehmet Ersatir},
journal = {Chemistry \& Biodiversity},
year = {2026},
month = nov,
doi = {10.1002/cbdv.71909},
url = {https://doi.org/10.1002/cbdv.71909},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Integrated Experimental and Computational Evaluation of Tri(p‐tolyl)phosphonium–Hydrazide Salts as AChE Inhibitors With Antimicrobial and Antibiofilm Activity Against Resistant Acinetobacter baumannii
AU - Metin Yıldırım
AU - Hakan Ünver
AU - Adem Necip
AU - Büsra Hord
AU - Mehmet Ersatir
PY - 2026
DA - 2026/11/12
JO - Chemistry & Biodiversity
DO - 10.1002/cbdv.71909
UR - https://doi.org/10.1002/cbdv.71909
AB - The rapid increase in multidrug‐resistant bacterial infections, particularly those caused by carbapenem‐resistant pathogens, represents an escalating global threat and necessitates the development of novel antimicrobial agents. In this study, a new series of tri(p‐tolyl)phosphonium‐hydrazide salts (1a–1g) was synthesized and structurally characterized using 1H‐NMR, 13C‐NMR, 31P‐NMR, and HR‐MS techniques. The antibacterial activity of the derivatives was assessed against carbapenem‐resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae, along with antibiofilm efficacy against A. baumannii. Compound 1d demonstrated the strongest antibacterial performance with a minimum inhibitory concentration value of 8 µg/mL against carbapenem‐resistant A. baumannii, and exhibited potent inhibition against the remaining strains. Given the multitarget therapeutic value, AChE inhibition was additionally evaluated, where compounds 1d and 1e showed appreciable activity with IC50 values of 5.392 µg/mL and 5.390 µg/mL, respectively. Molecular docking studies were conducted against clinically relevant protein targets (PDB: 4EY7, 6MPQ, 6GIE, 6OWS, 4DUH, 4DX5, and 4WUB) to further support the experimental outcomes. Compound 1d exhibited the highest binding affinity toward 6OWS with a docking score of −6.743 kcal/mol, correlating with its pronounced antibacterial efficacy. Collectively, these findings suggest that compound 1d holds promise as a potent antimicrobial candidate against drug‐resistant bacterial infections while also offering secondary therapeutic potential through AChE inhibition.
SN - 1612-1872
SN - 1612-1880
ER -